Gypenoside XLIX | CAS:94987-08-3 | Manufacturer ChemFaces

Gypenoside XLIX

ChemFaces products have been cited in many studies from excellent and top scientific journals

Product Name	Gypenoside XLIX
Price:	$118 / 20mg
CAS No.:	94987-08-3
Catalog No.:	CFN99717
Molecular Formula:	C₅₂H₈₆O₂₁
Molecular Weight:	1047.23 g/mol
Purity:	>=98%
Type of Compound:	Triterpenoids
Physical Desc.:	White powder
Source:	The herbs of Gynostemma pentaphyllum (Thunb.) Makino.
Solvent:	DMSO, Pyridine, Methanol, Ethanol, etc.
Download:	COA MSDS SDF Manual
Similar structural:	Comparison (Web) (SDF)
Guestbook:

Order & Inquiry & Tech Support

Tel: (0086)-27-84237683
Tech: service@chemfaces.com
Order: manager@chemfaces.com
Address: 176, CheCheng Eest Rd., WETDZ, Wuhan, Hubei 430056, PRC

How to Order

Orders via your E-mail:

1. Product number / Name / CAS No.
2. Delivery address
3. Ordering/billing address
4. Contact information
Order: manager@chemfaces.com

Delivery time

Delivery & Payment method

1. Usually delivery time: Next day delivery by 9:00 a.m. Order now

2. We accept: Wire transfer & Credit card & Paypal

Citing Use of our Products

More Impact Factor than five Cite...

* Packaging according to customer requirements(5mg, 10mg, 20mg and more). We shipped via FedEx, DHL, UPS, EMS and others courier.

According to end customer requirements, ChemFaces provide solvent format. This solvent format of product intended use: Signaling Inhibitors, Biological activities or Pharmacological activities.

Size /Price /Stock	10 mM * 1 mL in DMSO / $68.5 / In-stock
Other Packaging	*Packaging according to customer requirements(100uL/well, 200uL/well and more), and Container use Storage Tube With Screw Cap

Featured Products

More...

Coumestrol

Catalog No: CFN96040
CAS No: 479-13-0
Price: $178/10mg

Quercetin-3-O-glucuronide

Catalog No: CFN92172
CAS No: 22688-79-5
Price: $238/20mg

Quercetin

Catalog No: CFN99272
CAS No: 117-39-5
Price: $40/20mg

Chebulanin

Catalog No: CFN92294
CAS No: 166833-80-3
Price: $ / mg

Ganoderic acid DM

Catalog No: CFN99815
CAS No: 173075-45-1
Price: $318/5mg

Guaiol

Catalog No: CFN96326
CAS No: 489-86-1
Price: $ / mg

Rosavin

Catalog No: CFN99179
CAS No: 84954-92-7
Price: $68/20mg

Aromadendrin

Catalog No: CFN98736
CAS No: 480-20-6
Price: $318/20mg

Vincristine sulfate

Catalog No: CFN90400
CAS No: 2068-78-2
Price: $138/20mg

Noroxyhydrastinine

Catalog No: CFN90504
CAS No: 21796-14-5
Price: $318/5mg

Description:

Gypenoside XLIX, a naturally occurring gynosaponin, inhibits NF-kappaB activation via a PPAR-alpha-dependent pathway, it may treat inflammatory and cardiovascular diseases, including atherosclerosis.

Targets:

PPAR | TNF-α | NF-kB | p65

In vitro:

J Biomed Sci. 2006 Jul;13(4):535-48.

Gypenoside XLIX isolated from Gynostemma pentaphyllum inhibits nuclear factor-kappaB activation via a PPAR-alpha-dependent pathway.[Pubmed: 16525884]

Nuclear factor (NF)-kappaB is important in the generation of inflammation. Besides regulating lipid metabolism, peroxisome proliferator-activated receptor (PPAR)-alpha activators also reduce NF-kappaB activation to terminate activation of inflammatory pathways. Gynostemma pentaphyllum (GP) has been used to treat various inflammatory diseases and hyperlipidemia.
METHODS AND RESULTS:
Here, we demonstrate that GP extract and one of its main components, Gypenoside XLIX (Gyp-XLIX) inhibited LPS-induced NF-kappaB activation in murine macrophages. Furthermore, Gyp-XLIX restored the LPS- and TNF-alpha-induced decrease in cytosolic I-kappaBalpha protein expression and inhibited the translocation of NF-kappaB(p65) to the nucleus in THP-1 monocyte and HUVEC cells. The inhibition of LPS- and TNF-alpha-induced NF-kappaB luciferase activity in macrophages was abolished by MK-886, a selective PPAR-alpha antagonist. GP extract and Gyp-XLIX (EC(50): 10.1 microM) enhanced PPAR-alpha luciferase activity in HEK293 cells transfected with the tK-PPREx3-Luc reporter plasmid and expression vectors for PPAR-alpha. Additionally, Gyp-XLIX specifically enhanced PPAR-alpha mRNA and protein expression in THP-1-derived macrophage cells. The selectivity of Gyp-XLIX for PPAR-alpha was demonstrated by the activation of only PPAR-alpha in HEK293 cells transfected with expression vectors for PPAR-alpha, PPAR-beta/delta or PPAR-gamma1 plasmids and in THP-1-derived macrophage naturally expressing all three PPAR isoforms.
CONCLUSIONS:
The present study demonstrates that Gyp-XLIX, a naturally occurring gynosaponin, inhibits NF-kappaB activation via a PPAR-alpha-dependent pathway.

Gypenoside XLIX Description

Source:	The herbs of Gynostemma pentaphyllum (Thunb.) Makino.
Solvent:	DMSO, Pyridine, Methanol, Ethanol, etc.
Storage:	Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C). Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com
After receiving:	The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.

Cell Research:

Toxicol Appl Pharmacol. 2007 Jan 1;218(1):30-6.

Gypenoside XLIX, a naturally occurring gynosaponin, PPAR-alpha dependently inhibits LPS-induced tissue factor expression and activity in human THP-1 monocytic cells.[Pubmed: 17141290]

Tissue factor (TF) is involved not only in the progression of atherosclerosis and other cardiovascular diseases, but is also associated with tumor growth, metastasis, and angiogenesis and hence may be an attractive target for directed cancer therapeutics. Gynostemma pentaphyllum (GP) is widely used in the treatment of various cardiovascular diseases including atherosclerosis, as well as cancers. Gypenoside (Gyp) XLIX, a dammarane-type glycoside, is one of the prominent components in GP. We have recently reported Gypenoside XLIX to be a potent peroxisome proliferator-activated receptor (PPAR)-alpha activator.
METHODS AND RESULTS:
Here we demonstrate that Gypenoside XLIX (0-300 microM) concentration dependently inhibited TF promoter activity after induction by the inflammatory stimulus lipopolysaccharide (LPS) in human monocytic THP-1 cells transfected with promoter reporter constructs pTF-LUC. Furthermore, Gypenoside XLIX inhibited LPS-induced TF mRNA and protein overexpression in THP-1 monocyte cells. Its inhibition of LPS-induced TF hyperactivity was further confirmed by chromogenic enzyme activity assay. The activities of Gypenoside XLIX reported in this study were similar to those of Wy-14643, a potent synthetic PPAR-alpha activator. Furthermore, the Gypenoside XLIX-induced inhibitory effect on TF luciferase activity was completely abolished in the presence of the PPAR-alpha selective antagonist MK-886.
CONCLUSIONS:
The present findings suggest that Gypenoside XLIX inhibits LPS-induced TF overexpression and enhancement of its activity in human THP-1 monocytic cells via PPAR-alpha-dependent pathways. The data provide new insights into the basis of the use of the traditional Chinese herbal medicine G. pentaphyllum for the treatment of cardiovascular and inflammatory diseases, as well as cancers.

Structure Identification:

Yao Xue Xue Bao. 1997 Jul;32(7):524-9.

[Studies on the chemical constituents of Gynostemma longipes C.Y. Wu].[Pubmed: 11596278]

METHODS AND RESULTS:
A new triterpenoid saponin named gylongiposide I was isolated from the aerial parts of Gynostemma longipes C.Y. Wu. On the basis of chemical evidence and spectral data the structure of gylongiposide I was elucidated as 19-oxo-3 beta, 20(S), 21-trihydroxydammar-24-ene-3-O-([alpha-L-rhamnopyranosy(1-->2)] [beta-D-xylpyranosyl(1-->3)]) alpha-L-arabinopyranoside (G).
CONCLUSIONS:
The known compounds were identified as Gypenoside XLIX(F) and ginsenoside Rb1(A).

Size /Price /Stock	10 mM * 100 uL in DMSO / Inquiry / In-stock 10 mM * 1 mL in DMSO / Inquiry / In-stock
Related Libraries	Anti-inflammatory Compound Library Triterpenoids Compound Library TNF-α Inhibitor Library PPAR Inhibitor Library p65 Inhibitor Library NF-kB Inhibitor Library

	1 mg	5 mg	10 mg	20 mg	25 mg
1 mM	0.9549 mL	4.7745 mL	9.549 mL	19.098 mL	23.8725 mL
5 mM	0.191 mL	0.9549 mL	1.9098 mL	3.8196 mL	4.7745 mL
10 mM	0.0955 mL	0.4775 mL	0.9549 mL	1.9098 mL	2.3873 mL
50 mM	0.0191 mL	0.0955 mL	0.191 mL	0.382 mL	0.4775 mL
100 mM	0.0095 mL	0.0477 mL	0.0955 mL	0.191 mL	0.2387 mL

CFN97232	20,24-Dihydroxydammar-25-en-3-one	75069-59-9	458.7	C₃₀H₅₀O₃
CFN97092	24,25-Epoxydammar-20(21)-en-3-one	63543-52-2	440.7	C₃₀H₄₈O₂
CFN98922	Dammar-20(21)-en-3,24,25-triol	55050-69-6	460.7	C₃₀H₅₂O₃
CFN97093	24,25-Dihydroxydammar-20-en-3-one	63543-53-3	458.7	C₃₀H₅₀O₃
CFN90349	25(R)-Hydroxyprotopanaxadiol	83349-37-5	478.75	C₃₀H₅₄O₄
CFN90351	25(S)-Hydroxyprotopanaxatriol	113539-03-0	494.75	C₃₀H₅₄O₅
CFN99717	Gypenoside XLIX	94987-08-3	1047.23	C₅₂H₈₆O₂₁
CFN96019	Palbinone	139954-00-0	358.5	C₂₂H₃₀O₄
CFN96254	Dammarenediol II 3-O-caffeate	171438-55-4	606.9	C₃₉H₅₈O₅
CFN98705	Dipterocarpol	471-69-2	442.7	C₃₀H₅₀O₂